Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
10 June 2019 | Story Lacea Loader

The executive committee of the University of the Free State (UFS) has today resumed the training of its undergraduate students in the School of Clinical Medicine at the Pelonomi Hospital in Bloemfontein with immediate effect.

The decision to suspend the training of undergraduate students at the hospital came after the attempted rape of a medical intern last week, as well as the robbery of a medical officer in the parking area of the hospital over the weekend.

This morning, discussions involving the university management, the Head of the Department of Health (DoH) in the Free State Province, the executive committee of the Pelonomi Hospital, and the South African Police Service (SAPS) took place regarding the security situation at the hospital. The DoH provided the university with a security project plan comprising immediate and medium-term interventions, and a commitment to execute the plan as a matter of urgency. The university’s executive management furthermore met with the management of the Faculty of Health Sciences and, based on a safety risk assessment, the university’s executive management agreed that undergraduate students could again fully access the clinical platform at Pelonomi Hospital.

Interventions in the security project plan include the installation of high-mast lights in the precinct of the hospital, reparation of the perimeter fence, security locks, and limiting access to the hospital and the hospital grounds after 20:00 until 06:00. A Venue Operation Centre (VOC) made up of SAPS, institutional security management, and the Community Policing Forum will also be established at the hospital.

“The main focus and concern for the executive management of the university is the safety of its students and staff. We are satisfied with the security plan and the overall interventions committed to by the DoH and will monitor the implementation of these interventions with the management of the Pelonomi Hospital and the DoH. The security interventions will alleviate the situation at the hospital in order for the university to continue sending its undergraduate students there for training,” said Prof Francis Petersen, UFS Rector and Vice-Chancellor, during a media briefing today.

Prof Petersen also met with undergraduate students in the Schools of Clinical Medicine, Nursing, and Allied Health Professions today to discuss the situation at the hospital. Trauma counselling is provided to undergraduate students and staff and those in need of counselling at the Pelonomi Hospital.

The DoH has furthermore extended its bus service between the clinical platforms in Bloemfontein to students in need of transport of the School of Clinical Medicine according to time slots as from the beginning of the second semester. This service will ultimately be extended to undergraduate students in the Schools of Nursing and Allied Health Professions. “We will also look into further transport solutions for the longer term for our students,” said Prof Petersen.

Undergraduate students from the university’s Schools of Clinical Medicine, Nursing, and Allied Health Professions are trained on the clinical platforms in Bloemfontein – these include the Pelonomi Hospital, Universitas Hospital, National Hospital, the Mangaung University Community Partnership Programme (MUCPP), and the Free State Psychiatric Complex.

Although these clinical training platforms are under the jurisdiction of the DoH in the Free State Province, they form a critical part of the training of undergraduate students in the university’s Faculty of Health Sciences. Staff on the joint establishment of the UFS and the DoH also work at hospitals on the clinical platforms.

Released by:
Lacea Loader (Director: Department of Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
E-mail: news@ufs.ac.za | loaderl@ufs.ac.za


News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept